Alice Melão,  —

Articles by Alice Melão

Preliminary Data Further Show MarzAA’s Potential to Prevent Bleedings

Clinical data from the ongoing Phase 2/3 trial data evaluating MarzAA (marzeptacog alfa activated) in patients with Hemophilia A or B with inhibitors continues to demonstrate the treatment’s potential to prevent bleedings. The most recent trial results were discussed at the 12th Annual Congress of the European Association for…